Company / Cash per Share
Savara Inc Cash per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$0.08
FY2024
5-year range
$0.08 / $0.63
FY2020-FY2024
Trend
-52.6%
vs FY2023
Sector context
#203 of 205
Health Care
What the data says
Among 205 Health Care companies, Savara Inc is in the bottom 1% for cash per share. Cash per Share has declined for 3 consecutive years, from $0.63 in FY2021 to $0.08 in FY2024.
Based on SEC 10-K filings.
0.08 in FY2024 with a 5-year CAGR of -44.2%.
Declined from $0.34 to $0.08 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -50.5%
- 5-Year CAGR
- -44.2%
- 10-Year CAGR
- -
Sector benchmark
Bottom 1% in Health CareTop 99% of 205This company $0.08 Sector average $72.93
▼
-99.9% below sector average
Key checks
Key Insights
- Savara Inc's cash per share has declined for 3 consecutive years.
- In FY2024, cash per share decreased 52.6% year-over-year.
- Ranks #203 out of 205 companies in the Health Care sector.
- Peak cash per share was recorded in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.86 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.08 | -52.6% |
| FY2023 | $0.16 | -52.8% |
| FY2022 | $0.34 | -45.7% |
| FY2021 | $0.63 | +39.4% |
| FY2020 | $0.45 | -68.2% |
| FY2019 | $1.42 | +94.2% |
| FY2018 | $0.73 | -89.6% |
| FY2017 | $6.99 | +8457.7% |
| FY2016 | $0.08 | -21.9% |
| FY2015 | $0.10 | -15.3% |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026